116 related articles for article (PubMed ID: 28837806)
21. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
[TBL] [Abstract][Full Text] [Related]
22. Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3.
Cassar L; Nicholls C; Pinto AR; Li H; Liu JP
FASEB J; 2009 Jun; 23(6):1880-92. PubMed ID: 19193721
[TBL] [Abstract][Full Text] [Related]
23. Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells.
Khaw AK; Hande MP; Kalthur G; Hande MP
J Cell Biochem; 2013 Jun; 114(6):1257-70. PubMed ID: 23192708
[TBL] [Abstract][Full Text] [Related]
24. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
[TBL] [Abstract][Full Text] [Related]
25. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
Jagadeesh S; Kyo S; Banerjee PP
Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
[TBL] [Abstract][Full Text] [Related]
27. Study on the mechanism of xiaotan sanjie recipe for inhibiting proliferation of gastric cancer cells.
Li CJ; Wei PK; Yue BL
J Tradit Chin Med; 2010 Dec; 30(4):249-53. PubMed ID: 21287780
[TBL] [Abstract][Full Text] [Related]
28. Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells.
Luo Y; Yi Y; Yao Z
Cancer Invest; 2009 Dec; 27(10):960-70. PubMed ID: 19909010
[TBL] [Abstract][Full Text] [Related]
29. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.
Delhommeau F; Thierry A; Feneux D; Lauret E; Leclercq E; Courtier MH; Sainteny F; Vainchenker W; Bennaceur-Griscelli A
Oncogene; 2002 Nov; 21(54):8262-71. PubMed ID: 12447689
[TBL] [Abstract][Full Text] [Related]
30. miR-512-5p suppresses tumor growth by targeting hTERT in telomerase positive head and neck squamous cell carcinoma in vitro and in vivo.
Li J; Lei H; Xu Y; Tao ZZ
PLoS One; 2015; 10(8):e0135265. PubMed ID: 26258591
[TBL] [Abstract][Full Text] [Related]
31. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA
Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711
[TBL] [Abstract][Full Text] [Related]
32. A novel oncolytic adenovirus targeting to telomerase activity in tumor cells with potent.
Zou W; Luo C; Zhang Z; Liu J; Gu J; Pei Z; Qian C; Liu X
Oncogene; 2004 Jan; 23(2):457-64. PubMed ID: 14724574
[TBL] [Abstract][Full Text] [Related]
33. MST-312 Alters Telomere Dynamics, Gene Expression Profiles and Growth in Human Breast Cancer Cells.
Gurung RL; Lim SN; Low GK; Hande MP
J Nutrigenet Nutrigenomics; 2014; 7(4-6):283-98. PubMed ID: 26022559
[TBL] [Abstract][Full Text] [Related]
34. [Bacterial recombinant L-asparaginases: properties, structure and anti-proliferative activity].
Sokolov NN; Eldarov MA; Pokrovskaya MV; Aleksandrova SS; Abakumova OY; Podobed OV; Melik-Nubarov NS; Kudryashova EV; Grishin DV; Archakov AI
Biomed Khim; 2015; 61(3):312-24. PubMed ID: 26215408
[TBL] [Abstract][Full Text] [Related]
35. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Raymond E; Faivre S; Dieras V; Von Hoff D
Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of telomerase enhances apoptosis induced by sodium butyrate via mitochondrial pathway.
Xi L; Chen G; Zhou J; Xu G; Wang S; Wu P; Zhu T; Zhang A; Yang W; Xu Q; Lu Y; Ma D
Apoptosis; 2006 May; 11(5):789-98. PubMed ID: 16554963
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment.
Gandellini P; Folini M; Bandiera R; De Cesare M; Binda M; Veronese S; Daidone MG; Zunino F; Zaffaroni N
Biochem Pharmacol; 2007 Jun; 73(11):1703-14. PubMed ID: 17321502
[TBL] [Abstract][Full Text] [Related]
38. Anticancer therapy targeting telomeres and telomerase : current status.
Parkinson EK; Minty F
BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
[TBL] [Abstract][Full Text] [Related]
39. Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy.
Nakajima A; Tauchi T; Sashida G; Sumi M; Abe K; Yamamoto K; Ohyashiki JH; Ohyashiki K
Leukemia; 2003 Mar; 17(3):560-7. PubMed ID: 12646945
[TBL] [Abstract][Full Text] [Related]
40. Induction of telomere dysfunction mediated by the telomerase substrate precursor 6-thio-2'-deoxyguanosine.
Mender I; Gryaznov S; Dikmen ZG; Wright WE; Shay JW
Cancer Discov; 2015 Jan; 5(1):82-95. PubMed ID: 25516420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
